Technical Articles
CAR-NK
Where IL-15 Stands in NK Cell Therapy: Three Routes and the Evidence Each Demands
From ex vivo NK expansion to IL-15 superagonist fusions and CAR-NK programs, IL-15 sits at the evidence gate of each route. This article traces the chain.
View details
- Immunity/Inflamma
- IL-15
- NK cell therapy
- CAR-NK
- IL-15 superagonist
- ex vivo expansion
- UA040010
- 1






